Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab

Author:

Friedlaender Alex1,Metro Giulio2,Signorelli Diego3,Gili Alessio4,Economopoulou Panagiota5,Roila Fausto2,Banna Giuseppe6,De Toma Alessandro3,Camerini Andrea7,Christopoulou Athina8,Lo Russo Giuseppe3,Banini Marco2,Galetta Domenico9,Jimenez Beatriz10,Collazo-Lorduy Ana10,Calles Antonio11,Baxevanos Panagiotis12,Linardou Helena13,Kosmidis Paris14,Mountzios Giannis15,Garassino Marina C.3,Addeo Alfredo1ORCID

Affiliation:

1. Department of Oncology, Geneva University Hospital, Geneva, Switzerland;

2. Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy;

3. Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale Tumori di Milano, Milano, Italy;

4. Public Health Section, Department of Experimental Medicine, University of Perugia, Perugia, Italy;

5. Oncology Department, Attikon University Hospital, Athens, Greece;

6. Medical Oncology, Ospedale Cannizzaro, Catania, Italy;

7. U.O.C. Oncologia, Ospedale Versilia, Lido di Camaiore (LU), Italy;

8. Medical Oncology, Agios Andreas General Hospital of Patras, Patras, Greece;

9. Medical Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy;

10. Medical Oncology, Hospital Universitario HM Sanchinarro, Madrid, Spain;

11. Division of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain;

12. Second Department of Medical Oncology, Saint Savvas Anti-Cancer Hospital, Athens, Greece;

13. First Department of Medical Oncology, Metropolitan Hospital, Athens, Greece;

14. Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece;

15. Second Department of Medical Oncology, Henry Dunant Hospital Center, Athens, Greece

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3